The transdermal composition of claim 2 wherein polymer is selected from one or more of polyethylene glycol, methacrylate copolymers (Eudragits), Acrylic copolymer, Polyster Film/copolymer of ethylene and vinyl acetate, Poly (Butyl methacrylate, methyl methacrylate), cellulose polymers (carboxymethylcellulose, ethyl cellulose, hydroxypropylmethylcellulose hydroxypropylcellulose), polyvinylpyrrolidone, polymer of acrylic acid crosslinked with allyl ethers of polyalcohols (carbomer / carbopol)
Protocol: Dosing typically follows a titration schedule , starting at a low dose (e.g., 0.3 mg) and gradually escalating every four weeks until the target dose (2.4 mg) is achieved
Lm trng da ton thn, tr nm, tn nhang t su bn trong Lm chm qu trnh lo ha t nhin do tui tc, gip tr ha ln da, bo v da khe mnh trc cc tc nhn gy hi cho da
Paracetamol (Acetaminophen): mechanisms of action
Antioxidant activity of quercetin and its glucosides from propolis: a theoretical study
GH is essential for growth, metabolism, and cell regeneration